Evidence map›Paper›PMID 32481273›Full record

Observational studyMedicine2020

Comparison of adherence measurement tools used in a pre-exposure prophylaxis demonstration study among female sex workers in Benin.

Aminata Mboup, Luc Béhanzin, Fernand Guédou, Katia Giguère, Nassirou Geraldo, Djimon Marcel Zannou, René K Kêkê, Moussa Bachabi, Flore Gangbo, Dissou Affolabi and 4 more

Open access · goldAbstract readComparative StudyObservational Study
In one paragraph

Observational study in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 5 countries.

Aminata MboupDépartement de médecine sociale et préventive, Université Laval.
Luc BéhanzinDépartement de médecine sociale et préventive, Université Laval.
Fernand GuédouDépartement de médecine sociale et préventive, Université Laval.
Katia GiguèreDépartement de médecine sociale et préventive, Université Laval.
Nassirou GeraldoDispensaire IST, Cotonou, Bénin.
Djimon Marcel ZannouFaculté des sciences de la santé, Université d'Abomey-Calavi.
René K KêkêProgramme Santé de Lutte contre le Sida (PSLS).
Moussa BachabiProgramme Santé de Lutte contre le Sida (PSLS).
Flore GangboProgramme Santé de Lutte contre le Sida (PSLS).
Dissou AffolabiFaculté des sciences de la santé, Université d'Abomey-Calavi.
Mark A MarzinkeJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Craig HendrixJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Souleymane DiabatéDépartement de médecine sociale et préventive, Université Laval.
Michel AlaryDépartement de médecine sociale et préventive, Université Laval.
Comité National de Lutte contre le SIDA · CMUniversité Laval · CACentre hospitalier de l'Université Laval · CAJohns Hopkins University · USCentre National Hospitalier et Universitaire Hubert Koutoukou MAGA · BJUniversité d'Abomey-Calavi · BJUniversité de Parakou · BJ

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
NIAID NIH HHS P30 AI094189
6 · The paper itself

Abstract

backgroundMeasuring adherence to PrEP (pre-exposure prophylaxis) remains challenging. Biological adherence measurements are reported to be more accurate than self-reports and pill counts but can be expensive and not suitable on a daily basis in resource-limited countries. Using data from a demonstration project on PrEP among female sex workers in Benin, we aimed to measure adherence to PrEP and compare self-report and pill count adherence to tenofovir (TFV) disoproxil fumarate (TDF) concentration in plasma to determine if these 2 measures are reliable and correlate well with biological adherence measurements.

methodsPlasma TFV concentrations were analyzed in samples collected at day 14 follow-up visit and months 6, 12, 18, and 24 (or at last visit when follow-up was shorter). Self-reported adherence was captured at day 14 follow-up visit and then quarterly by asking participants to report the number of missed pills within the last week. For pill count, medications were refilled monthly and participants were asked to bring in their medication bottles at each follow-up visit. Using generalized estimating equations adherence measured by self-report and pill count was compared to plasma drug concentrations.

resultsOf 255 participants, 47.1% completed follow-up. Weighted optimal adherence combining data from all visits was 26.8% for TFV concentration, 56.0% by self-report and 18.9% by pill count. Adherence measured by both TFV concentrations and self-report decreased over time (P = .009 and P = .019, respectively), while the decreasing trend in adherence by pill count was not significant (P = .087). The decrease in adherence was greater using TFV concentrations than the other 2 adherence measures.

conclusionWith high levels of misreporting of adherence using self-report and pill count, the objective biomedical assessment of adherence via laboratory testing is optimal and more accurately reflects PrEP uptake and persistence. Alternative inexpensive and accurate approaches to monitor PrEP adherence should be investigated.

Indexed as

Drug MonitoringAdultAnti-HIV AgentsBeninFemaleHIV InfectionsHumansMiddle AgedPre-Exposure ProphylaxisSelf ReportSex WorkersTenofovirAnti-HIV AgentsTenofovir

Identifiers

PMID32481273
PMCPMC7249870
OpenAlexW3028642875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.